Mutual Fund Ownership
Ownership as on: Sat, 2 Nov, 2024

Quant Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)27.79
% of AUM6.12%

Aditya Birla Sun Life MNC Fund Growth

NA
Equity
Amount Invested (Cr.)131.76
% of AUM3.15%

Samco Flexi Cap Fund Regular Growth

NA
Equity
Amount Invested (Cr.)19.27
% of AUM2.94%

Shriram Multi Asset Allocation Fund Regular Growth

NA
Hybrid
Amount Invested (Cr.)4.94
% of AUM2.81%

Samco ELSS Tax Saver Fund Regular Growth

NA
Equity
Amount Invested (Cr.)3.36
% of AUM2.75%

FAQs about Glaxosmithkline Pharmaceuticals share price

Glaxosmithkline Pharmaceuticals is trading at 2723.20 as on Fri Nov 01 2024 13:29:54. This is 0.13% upper as compared to its previous closing price of 2719.80.

The market capitalization of Glaxosmithkline Pharmaceuticals is 46132.65 Cr as on Fri Nov 01 2024 13:29:54.

The average broker rating on Glaxosmithkline Pharmaceuticals is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Glaxosmithkline Pharmaceuticals is 3087.95 whereas the 52 wk low is 1387.90

Glaxosmithkline Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 69.45
  • Sector P/E: 33.75
  • Dividend Yield: 1.18%
  • D/E ratio: 0.01

Glaxosmithkline Pharmaceuticals reported a net profit of 589.96 Cr in 2024.

Recommended For You
Trending Stocks
2,817.00+89.65(3.29%)
843.60+9.50(1.14%)
1,169.20+10.70(0.92%)
1,758.20-9.75 (-0.55%)
1,603.00-5.25 (-0.33%)
HomeMarketsPremiumInstant LoanMint Shorts